New research shows top executives at Pfizer, Moderna, Merck and other vaccine manufacturers sold nearly $500 million of stock last year as the value in the companies soared due to the pandemic.
Top Executives at Vaccine Manufacturers Sold $500 Million in Stocks Last Year
HeadlineFeb 18, 2021